Spinal Cord Infarction: TACE & HCC – A Rare Case Report

The Rising Risk of Spinal Cord Infarction Post-Hepatocellular Carcinoma Treatment: What the Future Holds Imagine a scenario: a patient, relieved to have undergone successful transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), suddenly experiences debilitating weakness and sensory loss. While TACE is a vital treatment for liver cancer, a growing body of evidence, highlighted by recent … Read more

Antimicrobial Resistance: Global Trends & Projections

The Looming Threat Beyond Antibiotics: Why Current Resistance Estimates May Be Vastly Understated Every year, an estimated 1.27 million deaths globally are directly attributable to antibiotic-resistant infections. But a recent, comprehensive analysis suggests that number is a significant undercount – potentially by millions. While the GBD 2021 Antimicrobial Resistance Collaborators’ work is a crucial step … Read more

COVID-19: High Disease Burden Still Impacts Health

COVID-19: High Disease Burden Still Impacts Health

COVID-19’s Enduring Impact: Why Public Health Can’t Afford to Move On Even as life returns to a semblance of normalcy, a recent study from Denmark reveals a stark reality: COVID-19 continues to pose a significantly greater threat than influenza, resulting in more hospitalizations and deaths. This isn’t a fading echo of a pandemic past; it’s … Read more

Moderna’s New COVID Vaccine Approved with Limits

Moderna’s New COVID Vaccine Approved with Limits

The Fragmenting Future of Covid Vaccines: Moderna’s New Shot and a Shifting Landscape Over 47,000 Americans died from Covid-19 last year, a stark reminder that the virus remains a significant public health threat. But the response to that threat is undergoing a fundamental shift. Late Friday, the FDA approved Moderna’s next-generation Covid-19 vaccine, mNexspike, yet … Read more